NPI 1184100067: Open Payments
NPI 1184100067. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$67 in 4 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $59 · 2025 $67
Food & beverage: $67
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $17 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $16 |
| Corium, LLC | 1 | $14 |
Products named: REXULTI, INJECTAFER, Azstarys.
